Ausgewählte Vorträge
2018
- "Development of MVA candidate vaccines against MERS." G. Sutter, WHO-IVI Joint Symposium for MERS-CoV Vaccine Development, 2018 Seoul Cyber University-IVI Global Vaccine Forum, Grand InterContinental Seoul Parnas, Seoul, Republic of Korea, 26.06.-27.06.2018
- "Modified vaccinia virus Ankara: History, value in basic research, and use in vector vaccines." G. Sutter, Tzu Chi University Symposium on Contemporary Virology, Tzu Chi University, Hualien, Taiwan, 31.05.-01.06.2018
- New vaccines against emerging zoonotic infections: From animal models to clinik." A. Volz, Tzu Chi University Symposium on Contemporary Virology, Tzu Chi University, Hualien, Taiwan, 31.05.-01.06.2018
- "Immunotherapeutic potential of oncolytic Vaccinia viruses." J. Rojas, Tzu Chi University Symposium on Contemporary Virology, Tzu Chi University, Hualien, Taiwan, 31.05.-01.06.2018
- "Influenza vaccines based on recombinant Modified Vaccinia virus Ankara.", G. Sutter, Guus Rimmelzwaan Farewell Symposium, EMC Rotterdam, The Netherlands, 23.03.2018
- "Vaccination Against Infectious Disease.", G. Sutter, Indo-German Cooperation in Health Research, ICMR Workshop, New Delhi, 18.-19.01.2018
2017
- "Making vaccine research & development more effective in the EU.", G. Sutter, Workshop: Seeking new partnerships for EU action on vaccination, European Commission, Square Brussels Meeting Centre, Brussels,
30.05.-31.05.2017 - "Vaccinia virus MVA as vector vaccine: From animal models to clinical evaluation.", G. Sutter, Vaccine Symposium, UMC Utrecht, The Netherlands, 14.09.2017
- "Poxviruses-based vaccines.", G. Sutter, Intervention Master LIVE: UE Vaccine Specific Applications, UCBL (Universite Claude Bernard) Campus Lyon la Doua, 08.11.2017
2016
- "Development of recombinant MVA-MERS-S for Phase I Clinical Evaluation: A candidate Vaccine against Middle East Respiratory Syndrome Coronavirus.", A. Volz, 35th Annual Meeting of the American Society for Virology, Blacksburg, Virginia, USA, 17.-22.06.2016
- "Development of MVA-MERS-S: A candidate vaccine for humans and camels.", G. Sutter, Leibniz Center Infection Symposium 2016 "Vaccines", Bernhard Nocht Institute, Hamburg, 28.-29.01.2016
2015
- "Recombinant vaccinia MVA expressing E and prM/M proteins of West Nile Virus for vaccine generation.", A. Volz, 25 th Annual Meeting of the Society for Virology, Bochum, 18.-21.03.2015
- "Modified Vaccinia virus Ankara induced rapid recruitment of neutrophils into the lung requires complement component C5.", M.H. Lehmann, 25 th Annual Meeting of the Society for Virology, Bochum, 18.-21.03.2015
- "Rekombinantes Vacciniavirus MVA zur schnellen Impfstoffentwicklung gegen West Nil Fieber, MERS und Ebola.", A. Volz, 9. Internationaler Kongress "Forum Life Science", Technische Universität München, Garching, 11.-12.03.2015
2014
- "Middle east respiratory syndrome Coronavirus spike protein delivered by modified Vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.", G. Sutter, XX International Poxvirus, Asfarvirus & Iridovirus Conference, Victoria BC, Canada, 26.09.-30.09.2014
- "Das Porcine Circovirus 2 - ein ubiquitär vorkommendes Virus neu entdeckt!", R. Fux, 33. Jahrestagung der DVG-Fachgruppe "AVID", Kloster Banz, Bad Staffelstein, 17.09.-19.09.2014
2013
- "Modified Vaccinia virus Ankara vectors for antigen delivery - from (pre)clinical evaluation to process development.", G. Sutter, 3rd Workshop European Network on Viral Vaccine Processes, Dechema - Haus, Frankfurt a.M., 25.11.-26.11.2013
- "Low dose immunization with Modified Vaccinia virus Ankara induces rapid in vivo expansion of protective CD8+T Cells.", A. Volz, Medical Biodefense Conference 2013, Munich, 22.-25.10.2013
- "Pitfalls of BVD Eradication.", R. Fux, Cattle Association of Veterinary Ireland, Galway, Irland, 11.-12.10.2013
- "Harzardous Orthopoxviruses: Pathogenesis of infection, prevention and treatment.", G. Sutter, NATO Bio Warfare Defence Awareness Course, NATO School, Oberammergau, 30.09.-04.10.2013
- "Recombinant vaccinia virus MVA expressing E and prM/M proteins of West Nile Virus.", G. Sutter, 5th European Congress of Virology, Lyon, France, 11.-14.09.2013
- "Recombinant vaccinia MVA - a platform for development of emergency vaccines.", G. Sutter, Global Virus Network (GVN) Meeting Munich,
30.05.-01.06. 2013 - "New Influenza vaccines: Types and modes of administration.", G. Sutter, ESWI Flu Summit - Brussels, 02.05.2013
- "Recombinant vaccinia MVA - a promising vaccine platform for pandemic influenza.", G. Sutter, 4th Symposium on Veterinary Sciences, ENVT, Toulouse, France, 11.-13.04.2013
- "Vaccinia MVA vectors against emerging infections: From animal models to clinical evaluation." , G. Sutter, Robert-Koch-Institut Berlin, 09.04.2013
2012
- "Deutsches Zentrum für Infektionsforschung (DZIF) - a new multicenter initiative in translational infection research.", G. Sutter, National Symposium on Zoonoses Research 2012 - Berlin, 10.-12.10.2012
- "Hazardous Orthopoxvirus infections: Pathogenesis, Prevention and Treatment.", G. Sutter, NATO Bio Warfare Defence Awareness Course - NATO SCHOOL Oberammergau, 01.-05.10.2012
- "Vaccinia virus MVA based vector vaccines. Basic features, regulatory requests, future options.", G. Sutter, Erasmus Postgraduate School Molecular Medicine, Course in Virology 2012, Rotterdam, The Netherlands, 07.06.2012
2011
- "Vaccines against Vector-Borne Diseases.", G. Sutter, 100th Anniversary NVvM & Scientific Spring Meeting 2011, Arnhem, The Netherlands, 18.-20.04.2011
2010
- "Inflammation essential to successful vaccination? Learning from poxviruses.", G. Sutter, Kloster Seeon, Bavaria / Germany, 09.-12.05.2010
- "Modifiziertes Vacciniavirus Ankara (mVA) - ein Münchner Impfvirus auf Weltreise und zurück.", G. Sutter, Institut für Virologie, Universität Leipzig, 29.04.2010
- "Poxvirus vaccines - immunostimulatory activities and protective capacity.", G. Sutter, Seminarvortrag MPI Magdeburg, 21.01.2010
2009
- "Vaccinia virus MVA based vaccines - immunostimulatory capacity and protection against virus challenge.", G. Sutter, 46th OHOLO Conference, Eilat, Israel, 25.-29.10.2009
- "Protective immunity and the sensing of viruses.", G. Sutter, Karolinska Institutet, Stockholm, 12.06.2009
- "Poxvirus host interaction in infection and immunization.", G. Sutter, Medizinische Hochschule Hannover, Kolloquium des IRTG 1273, Twincore-Institut, Hannover, 18.05.2009
- "Candidate Vaccines based on recombinant modified vaccinia virus Ankara (MVA).", G. Sutter, University of Helsinki, Faculty of Medicine, 08.05.2009
- "Candidate influenza vaccines based on recombinant vaccinia virus MVA.", G. Sutter, Seminars in Experimantal Medicine. Kantonspital St. Gallen, Switzerland, 25.03.2009